Ras family GTPases are critical components of cell regulatory systems that control proliferation, differentiation, and cell survival. Inappropriate regulation of these systems directly contributes to initiation and progression of human cancer. This proposal is directed at decoding the composition, organization, and function of cell regulatory networks engaged by Ras family GTPases. Our focus is on isolation of molecular fulcrums that can be exploited to deflect oncogenic Ras-induced corruption of cell proliferation and survival restraints.
Our specific aims are 1) mechanistic elaboration of TBK1 as an oncology target in oncogenic Ras associated cancers;2) capture of oncogenic Ras synthetic-lethal loci by matrix analysis of pangenomic RNAi screens;and 3) comprehensive mapping of the human kinome to EGF receptor signaling.

Public Health Relevance

Progress in annotation of the signaling repertoire of oncogenic Ras in human cancer presents an exciting opportunity to identify effective interventions for tumors harboring this mutation. The key bottleneck to progress has been the struggle to identify effective targetable pressure-points within the oncogenic Ras regulatory network. We are applying leading-edge strategies to decode the linchpin elements mediating oncogenic Ras transformation. The expected outcomes and impact of our proposal will be isolation of molecular fulcrums, selectively supporting oncogenic Ras-induced perturbation of regulatory networks, that can be exploited to undercut tumor cell proliferation and survival. We have extensive experience and institutional support to carry out this project.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-OBT-N (02))
Program Officer
Watson, Joanna M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Sw Medical Center Dallas
Anatomy/Cell Biology
Schools of Medicine
United States
Zip Code
Cooper, Jonathan M; Ou, Yi-Hung; McMillan, Elizabeth A et al. (2017) TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer. Cancer Res 77:5077-5094
Wang, Chensu; Niederstrasser, Hanspeter; Douglas, Peter M et al. (2017) Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespan. Nat Commun 8:2270
Eskiocak, Banu; McMillan, Elizabeth A; Mendiratta, Saurabh et al. (2017) Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma. Cancer Discov 7:832-851
Wang, Chensu; Zhao, Tian; Li, Yang et al. (2017) Investigation of endosome and lysosome biology by ultra pH-sensitive nanoprobes. Adv Drug Deliv Rev 113:87-96
Thomas, Jemima C; Cooper, Jonathan M; Clayton, Natasha S et al. (2016) Inhibition of Ral GTPases Using a Stapled Peptide Approach. J Biol Chem 291:18310-25
Fisher, Kurt W; Das, Binita; Kim, Hyun Seok et al. (2015) AMPK Promotes Aberrant PGC1? Expression To Support Human Colon Tumor Cell Survival. Mol Cell Biol 35:3866-79
Pineda, Carlos T; Ramanathan, Saumya; Fon Tacer, Klementina et al. (2015) Degradation of AMPK by a cancer-specific ubiquitin ligase. Cell 160:715-728
Borkowski, Robert; Du, Liqin; Zhao, Zhenze et al. (2015) Genetic mutation of p53 and suppression of the miR-17?92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling. Cancer Res 75:666-75
Potts, Malia B; McMillan, Elizabeth A; Rosales, Tracy I et al. (2015) Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin B. Nat Chem Biol 11:401-8
Torres, Michael J; Pandita, Raj K; Kulak, Ozlem et al. (2015) Role of the Exocyst Complex Component Sec6/8 in Genomic Stability. Mol Cell Biol 35:3633-45

Showing the most recent 10 out of 63 publications